Molecular Formula | C30H41FN4O12
|
Molar Mass | 668.66 |
Density | 1.260±0.06 g/cm3(Predicted) |
Boling Point | 914.2±65.0 °C(Predicted) |
Solubility | DMSO/DMF: ≥20 mM |
Appearance | White to slightly brown solid |
pKa | 10.26±0.46(Predicted) |
Storage Condition | Inert atmosphere,Store in freezer, under -20°C |
Physical and Chemical Properties | Bioactive Z-DEVD-FMK (Caspase-3 Inhibitor) is a specific and irreversible Caspase-3 inhibitor, which can also effectively inhibit caspase-6, caspase-7, caspase-8 and caspase-10. |
In vitro study | Z-DEVD-FMK (1-200 μm) inhibited D4-GDI lysis and apoptosis in a concentration-dependent manner. Z-DEVD-FMK reduced ceramide-induced cardiomyocyte death and significantly inhibited caspase 3 activation. Z-DEVD-FMK (100 μm) attenuated OxyHb-induced cell shedding in cultured brain microvascular endothelial cells, reduced activity by caspase-2 and -3, abolished OxyHb-induced DNA helices, and to prevent OxyHb induced PARP cleavage. Z-DEVD-FMK (μm) blocks the MPP-induced increase in caspase-3 enzyme activity. Z-DEVD-FMK dose-dependently blocked 6-OHDA-induced apoptosis with an IC50 of 18 μm. |
In vivo study | Z-DEVD-FMK, before and after injury, significantly reduce the apoptosis after trauma, and significantly improve the recovery of neurological function. |